DXC · DXC Technology Co
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBIT non-GAAP | 150M | Q1 FY27 | — |
|
|
|||
| Adjusted EBIT margin non-GAAP | 5% | Q1 FY27 | +0.0% |
|
|
|||
| Bookings | 3B | Q1 FY27 | — |
|
|
|||
| CES organic revenue growth non-GAAP | -3% | Three Months Ended June 30, 2026 | — |
| CES profit non-GAAP | $100M | Three Months Ended June 30, 2026 | — |
| CES profit margin non-GAAP | 8.1% | Three Months Ended June 30, 2026 | — |
| EBIT margin | 6.9% | Three Months Ended June 30, 2026 | — |
| Free cash flow non-GAAP | 314M | Q1 FY27 | — |
|
|
|||
| GIS organic revenue growth non-GAAP | -11.1% | Three Months Ended June 30, 2026 | — |
| GIS profit non-GAAP | $38M | Three Months Ended June 30, 2026 | — |
| GIS profit margin non-GAAP | 2.6% | Three Months Ended June 30, 2026 | — |
| Insurance organic revenue growth non-GAAP | 1.4% | Three Months Ended June 30, 2026 | — |
| Insurance profit non-GAAP | $34M | Three Months Ended June 30, 2026 | — |
| Insurance profit margin non-GAAP | 10.7% | Three Months Ended June 30, 2026 | — |
| Non-GAAP diluted earnings per share non-GAAP | $0.4 | Q1 FY27 | +0.0% |
|
|
|||
| Non-GAAP effective tax rate non-GAAP | 48.6% | Three Months Ended June 30, 2026 | — |
| Book to bill ratio | 0.98 | Full Fiscal Year 2026 | — |
|
|
|||
| Book to bill ratio (GIS) | 1.09 | Q3 FY2026 | — |
| Book to bill ratio (Insurance) | 0.93 | Q3 FY2026 | — |
| Free cash flow year to date non-GAAP | $603M | Nine Months Ended December 31, 2025 | — |
| Trailing Twelve month book to bill ratio | 1.02 | Q3 FY2026 | — |
| Trailing Twelve month book to bill ratio (CES) | 1.13 | Q3 FY2026 | — |
| Trailing Twelve month book to bill ratio (GIS) | 0.99 | Q3 FY2026 | — |
| Trailing Twelve month book to bill ratio (Insurance) | 0.73 | Q3 FY2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Information Technology Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
DXC
this stock
DXC Technology Co
|
$1.78B | -25.9% | -1.8% | 15.1 | 17.8% |
|
IBM
International Business Machines Corp
|
$223.44B | -19.9% | +7.6% | 21.0 | 2.4% |
|
ACN
Accenture plc
|
$115.48B | -31.7% | +7.4% | 13.8 | 4.9% |
|
INFY
Infosys Ltd
|
$48.72B | -32.5% | — | — | 3.6% |
|
CTSH
Cognizant Technology Solutions Corp
|
$29.09B | -26.6% | +7.0% | 13.3 | 9.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| DXC | +1.6% | +15.3% | -14.2% | -3.5% | -25.9% |
| SPY | -0.4% | +2.9% | +11.6% | +3.0% | +12.8% |
| vs SPY | +2.0% | +12.4% | -25.7% | -6.4% | -38.7% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.